118 related articles for article (PubMed ID: 7945983)
1. The reduction in alcohol intake produced by enalapril is not attenuated by centrally administered angiotensin inhibitors.
Robertson JM; Harding S; Grupp LA
Alcohol; 1994; 11(4):295-9. PubMed ID: 7945983
[TBL] [Abstract][Full Text] [Related]
2. Effects of angiotensin II and an angiotensin converting enzyme inhibitor on alcohol intake in P and NP rats.
Grupp LA
Pharmacol Biochem Behav; 1992 Jan; 41(1):105-8. PubMed ID: 1539057
[TBL] [Abstract][Full Text] [Related]
3. Bradykinin suppresses alcohol intake and plays a role in the suppression produced by an ACE inhibitor.
Robertson JM; Harding S; Grupp LA
Pharmacol Biochem Behav; 1993 Dec; 46(4):751-8. PubMed ID: 8309951
[TBL] [Abstract][Full Text] [Related]
4. Effect of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, on the activity of angiotensin converting enzyme from human kidney.
Hiwada K; Inoue Y; Kokubu T
Gen Pharmacol; 1990; 21(4):555-8. PubMed ID: 2165961
[TBL] [Abstract][Full Text] [Related]
5. The reduction in alcohol intake in rats by isoproterenol is attenuated by indomethacin but not enalapril: relationship to blood glucose levels.
Grupp LA; Lau V; Harding S
Psychopharmacology (Berl); 1998 Jul; 138(2):167-75. PubMed ID: 9718286
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin and captopril increase alcohol intake.
Fitts DA
Pharmacol Biochem Behav; 1993 May; 45(1):35-43. PubMed ID: 8516370
[TBL] [Abstract][Full Text] [Related]
7. Hypotensive effects of angiotensin II analogues and angiotensin converting enzyme inhibitors in water-deprived Brattleboro rats.
Tomlinson KC; Gardiner SM; Bennett T
J Cardiovasc Pharmacol; 1990 Apr; 15(4):562-8. PubMed ID: 1691384
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of the dipeptidyl peptidase inhibitors captopril, ramipril, and enalapril on water intake and sodium appetite of Sprague-Dawley rats.
Rowland NE; Fregly MJ
Behav Neurosci; 1988 Dec; 102(6):953-60. PubMed ID: 2850816
[TBL] [Abstract][Full Text] [Related]
9. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
[TBL] [Abstract][Full Text] [Related]
10. Chronic effects of SQ29,852, a new angiotensin converting enzyme (ACE) inhibitor with a phosphonic acid group, in experimental hypertensive rats.
Kishi K; Ikeda M
Gen Pharmacol; 1993 Jul; 24(4):863-6. PubMed ID: 8224740
[TBL] [Abstract][Full Text] [Related]
11. The reduction in alcohol drinking by peripherally injected angiotensin II is selectively mediated by the AT1 receptor subtype.
Grupp LA; Harding S
Pharmacol Biochem Behav; 1994 Mar; 47(3):385-92. PubMed ID: 8208755
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme inhibitors suppress the vascular renin-angiotensin system of spontaneously hypertensive rats.
Higashimori K; Nakamaru M; Tabuchi Y; Nagano M; Mikami H; Ogihara T; Inagami T
Am J Hypertens; 1991 Jan; 4(1 Pt 2):56S-59S. PubMed ID: 2009150
[TBL] [Abstract][Full Text] [Related]
13. Ceranapril (SQ 29,852), an orally active inhibitor of angiotensin converting enzyme (ACE).
DeForrest JM; Waldron TL; Harvey C; Scalese R; Hammerstone S; Powell JR; Karanewsky D
J Cardiovasc Pharmacol; 1990 Jul; 16(1):121-7. PubMed ID: 1696654
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin converting enzyme inhibitors reduce alcohol consumption: some possible mechanisms and important conditions for its therapeutic use.
Lingham T; Perlanski E; Grupp LA
Alcohol Clin Exp Res; 1990 Feb; 14(1):92-9. PubMed ID: 2178480
[TBL] [Abstract][Full Text] [Related]
15. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
McCaa RE; Gillespie JB
Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
[TBL] [Abstract][Full Text] [Related]
16. Two inhibitors of angiotensin-converting enzyme, enalapril and captopril, increase salt appetite of rats.
Minsker DH; Bagdon WJ; Robertson RT; Bokelman DL
J Toxicol Environ Health; 1984; 14(5-6):715-22. PubMed ID: 6097696
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin converting enzyme inhibitors attenuate ischemic brain metabolism in hypertensive rats.
Sadoshima S; Fujii K; Ooboshi H; Ibayashi S; Fujishima M
Stroke; 1993 Oct; 24(10):1561-6; discussion 1566-7. PubMed ID: 8378962
[TBL] [Abstract][Full Text] [Related]
18. The assessment of ACE activity in man following angiotensin I challenges: a comparison of cilazapril, captopril and enalapril.
Essig J; Belz GG; Wellstein A
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):217S-223S. PubMed ID: 2548551
[TBL] [Abstract][Full Text] [Related]
19. Comparison of captopril and enalapril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice.
Liu YH; Liu LY; Wu JX; Chen SX; Sun YX
J Cardiovasc Pharmacol; 2006 Jan; 47(1):82-8. PubMed ID: 16424790
[TBL] [Abstract][Full Text] [Related]
20. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
